Skip to main content
. 2019 Apr 3;11(4):466. doi: 10.3390/cancers11040466

Figure 2.

Figure 2

Expression of vimentin in malignant gliomas: (a) Western blot analysis of vimentin expression in human patient malignant glioma surgical specimens: OD—oligodendroglioma, AA—anaplastic astrocytoma, GBM—glioblastoma multiforme; compared with normal brain; (b) the mRNA transcript levels of vimentin according REMBRANDT database (http://www.betastasis.com/glioma/rembrandt), sample size: non-tumor n = 29, OD n = 67, AA n = 460, GBM n = 220; (c) survival curves based on high versus low vimentin mRNA expression obtained from the REMBRANDT database. The solid lines present data for samples with levels higher (red) or lower (green) than median of dataset; the dashed lines presents data for samples divided into two groups (higher—red or lower—green) based on the “optimal cut-off” algorithm [22].